Next Article in Journal
Computational Prediction of the Epitopes of HA1 Protein of Influenza Viruses to its Neutralizing Antibodies
Next Article in Special Issue
Current Approaches and Future Perspectives for Nanobodies in Stroke Diagnostic and Therapy
Previous Article in Journal / Special Issue
A Collection of Single-Domain Antibodies that Crowd Ricin Toxin’s Active Site
Open AccessReview

Single-Domain Antibodies and Their Formatting to Combat Viral Infections

1
VIB Center for Medical Biotechnology, 9052 Ghent, Belgium
2
Department of Biochemistry and Microbiology, Ghent University, 9052 Ghent, Belgium
3
Department of Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium
*
Author to whom correspondence should be addressed.
Antibodies 2019, 8(1), 1; https://doi.org/10.3390/antib8010001
Received: 30 November 2018 / Revised: 13 December 2018 / Accepted: 14 December 2018 / Published: 20 December 2018
(This article belongs to the Special Issue Nanobody)
Since their discovery in the 1990s, single-domain antibodies (VHHs), also known as Nanobodies®, have changed the landscape of affinity reagents. The outstanding solubility, stability, and specificity of VHHs, as well as their small size, ease of production and formatting flexibility favor VHHs over conventional antibody formats for many applications. The exceptional ease by which it is possible to fuse VHHs with different molecular modules has been particularly explored in the context of viral infections. In this review, we focus on VHH formats that have been developed to combat viruses including influenza viruses, human immunodeficiency virus-1 (HIV-1), and human respiratory syncytial virus (RSV). Such formats may significantly increase the affinity, half-life, breadth of protection of an antiviral VHH and reduce the risk of viral escape. In addition, VHHs can be equipped with effector functions, for example to guide components of the immune system with high precision to sites of viral infection. View Full-Text
Keywords: virus; nanobody; formatting; Fc-domain; half-life virus; nanobody; formatting; Fc-domain; half-life
Show Figures

Figure 1

MDPI and ACS Style

De Vlieger, D.; Ballegeer, M.; Rossey, I.; Schepens, B.; Saelens, X. Single-Domain Antibodies and Their Formatting to Combat Viral Infections. Antibodies 2019, 8, 1.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop